en

PRODUCT DETAIL

Mevlyq 0,44 mg/ml injekčný roztok

Code 5652E
MA number EU/1/23/1789/001
Product Form: sol inj 1x2 ml/0,88 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XX Other antineoplastic agents
L01XX41 Eribulin
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 09.02.2024
Validity: 09.02.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 23.02.2024
eu-flag.png sk-flag.png